Trusted life sciences real estate that serves your industry's needs

Life sciences real estate services: sequencing your real estate needs

Life sciences real estate requirements are technically complex, capital intensive, and atypical for real estate service providers whose primary focus is office or warehouse space. Time-to-market and funding are crucial factors in driving innovation and successful new pharmaceutical product launches, which, in turn, require laboratories, vivaria, pilot plants, and manufacturing facilities. Our life sciences real estate specialists understand the pharmaceutical product life cycle as well as the technical complexities that can create significant budgetary and scheduling risks. We’ve successfully addressed the risks that surround life sciences real estate decision-making throughout all phases of the product life cycle and across all technical aspects of planning, designing, engineering, and constructing any type of life science space.

Connect with my local life sciences real estate advisor


The centerpiece of our approach is how we integrate your technical and financial requirements into the life sciences real estate negotiation process, ensuring these requirements are incorporated accurately into the transaction documents. This fully integrated process enables our team to develop innovative strategies with credible budgets and schedules at early transaction stages, providing clients with the facts needed to make more fully informed decisions.

This transparent, risk averse, “cradle-to-grave” model creates seamless continuity and allows complete flexibility, maximizing the efficacy of our client’s internal resources on either a portfolio or transactional basis.

Life sciences real estate services include:

  • Strategic Real Estate Planning
  • Site Selection
  • Pre-Lease Budgeting and Scheduling
  • Lease Negotiation
  • Site Evaluation Due Diligence Oversight
  • Consultant Team Selection, Engagement and Oversight
  • Post-Lease Project Management
  • Construction Management

Under the microscope: Our 2024 outlook for life sciences

The life sciences real estate landscape in the United States is on the brink of exciting changes this year. The industry is being influenced by shifting funding dynamics, research breakthroughs using AI, a new wave of agricultural technology, workplace evolutions, strategic new revenue streams and so much more.

READ our 2024 outlook

U.S. life sciences market Q4 2023 insights

Despite the current surplus of lab/R&D supply across the country in the form of sublease space and new development, capital and labor markets show a healthy life science sector with a variety of indicators suggesting leasing activity will pick back up within the next 12-18 months.


Bay Area life sciences market update

The life science market experienced a significant boom amid the pandemic, but the terrain has swiftly evolved. The diminished appetite for high-risk life science research and development has led to a significant decrease of funding for the life science industry. It is crucial for both owners and occupiers to stay light on their feet to navigate and capitalize on today's rapidly changing environment.


Capitalizing on resurgence: U.S. life science IPOs poised to spark leasing demand in 2024 and 2025

Indicators point to a potential increase in life science IPOs in 2024, which could lead to an uptick in leasing activity.

Learn more
graph of number of completed and announced life science IPOs compared to leasing activity in the U.S. from 2015 to 2024

Venture capital funding shifts to favor smaller U.S. life sciences companies

Explore the changing landscape of venture capital funding in the U.S. life sciences sector, where smaller companies are attracting increased investment and driving demand for lab space.

Learn more
graph of venture capital funding in U.S. life science companies by employee count from 2016 to 2024

West Coast cities see the largest increase in life science related funding compared to pre-COVID levels

West Coast cities are seeing the largest increase in life science related funding compared to pre-COVID levels

Learn more
Change in life science related funding by city

Subscribe to Avison Young email communications for news, listing information, research reports and to learn more about our life sciences real estate services.

Life sciences commercial real estate news and updates

Life sciences ​industry overview

Driven by an aging population, steady funding sources, and an urgent need to discover and develop vaccines and treatments for COVID-19, growth in life sciences industries shows no sign of slowing down. Unique location and space use requirements have made the sector resilient, drawing the attention of real estate investors in need of the services of life science commercial real estate specialists.

Learn more

Key Contacts

Kathy Gigac, SIOR

    • Principal
    • Managing Director
    • Industrial
    • Life Sciences
    • Tenant Representation
    • Occupier Services
[email protected]

Baxter M. Walker, III, SIOR, CCIM

    • Principal, Occupier Solutions
    • Industrial
    • Tenant Representation
    • Occupier Services
    • Office
[email protected]